Monday, September 13, 2021 7:28:10 PM
On April 30, 2021, Douglas Anderson, the former officer, director and majority shareholder of
Company, entered into a Stock Purchase Agreement (the “SPA”) with HNO International, Inc.,
a Delaware corporation, of which Donald Owens is control person, to purchase 95,000,000 shares of
common stock and 10,000,000 shares of Series A Preferred Stock in the Company representing a
majority of the total issued and outstanding shares of Common Stock and
Series A Preferred Stock.
On April 30, 2021, the Company accepted the resignation from Douglas Anderson as the
Company’s President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary and
Chairman of the Board of Directors. Effective on the same date to fill the vacancies created by Mr.
Anderson’s resignations, the Company appointed Donald Owens as the Company’s President, Chief
Executive Officer, Chief Financial Officer, Treasurer, Secretary and Chairman of the Board of
Directors. These resignations are in connection with the consummation of the SPA and was not the result of any disagreement with Company on any matter relating to Company’s operations, policies
or practices
Recent HNOI News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:41:46 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/26/2024 05:15:10 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/05/2024 09:24:01 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/29/2024 08:54:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 06:09:19 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/08/2024 06:41:41 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/19/2023 07:59:18 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/27/2023 04:58:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 06:19:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/14/2023 08:16:41 PM
- Form 8-A12G - Registration of securities [Section 12(g)] • Edgar (US Regulatory) • 07/11/2023 07:04:59 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM